衰弱轨迹及其影响因素研究进展

doi:10.12114/j.issn.1007-9572.2024.0586

中国全科医学 ›› 2026, Vol. 29 ›› Issue (30): 4372-4378.DOI: 10.12114/j.issn.1007-9572.2024.0586

衰弱轨迹及其影响因素研究进展

贺洋¹, 杨荣¹, 沈灿¹, 易珊烨¹, 刘力滴¹, 赵茜¹, 万智²^,^*(), 廖晓阳¹^,^*()

1．610000　四川省成都市，四川大学华西医院特需医疗中心全科医学病房
2．610000　四川省成都市，四川大学华西医院急诊科

收稿日期:2024-12-15 修回日期:2025-06-25 出版日期:2026-10-20 发布日期:2026-09-02
通讯作者: 万智, 廖晓阳
作者贡献：
贺洋进行文章的构思及撰写；杨荣、刘力滴进行研究的实施与可行性分析；易珊烨进行资料收集和整理；沈灿、赵茜进行论文的修订；万智、廖晓阳负责文章的质量控制、审校，对文章整体负责及监督管理。

Progress in Research on the Trajectory of Frailty and Its Influencing Factors

HE Yang¹, YANG Rong¹, SHEN Can¹, YI Shanye¹, LIU Lidi¹, ZHAO Qian¹, WAN Zhi²^,^*(), LIAO Xiaoyang¹^,^*()

1. General Medicine Ward, Special Need Medical Center, West China Hospital, Sichuan University, Chengdu 610000, China
2. Department of Emergency Department, West China Hospital, Sichuan University, Chengdu 610000, China

Received:2024-12-15 Revised:2025-06-25 Published:2026-10-20 Online:2026-09-02
Contact: WAN Zhi, LIAO Xiaoyang

摘要/Abstract

摘要： 衰弱是一种与衰老相关的老年问题，会增加老年人发生不良事件的风险。随着人口老龄化进程的推进，衰弱问题受到了广泛关注。以往的研究主要集中在衰弱性上，以横断面研究为主，对衰弱轨迹（具有相似衰弱性的个体随时间的聚类）及其影响因素的研究并不明确，通过这些研究对衰弱进行早期干预的措施也不明确。本文总结了衰弱轨迹的危险因素最新临床研究进展，以期从不同角度分析影响衰弱轨迹的因素，为衰弱患者的综合管理提供新的思路。

关键词: 衰弱, 衰弱轨迹, 纵向研究, 危险因素, 综述

Abstract:

Frailty is a geriatric syndrome associated with aging, which increases the risk of adverse events in the elderly. With the progress of population aging, the problem of frailty has been widely concerned. Previous studies mainly focused on frailty, mainly cross-sectional studies, and the studies on frailty trajectory (clustering of individuals with similar frailty over time) and its influencing factors were not clear, and the measures for early intervention of frailty through these studies were not clear. This paper summarized the latest clinical research progress of the risk factors of the frailty trajectory, in order to analyze the factors affecting the frailty trajectory from different angles, and provide new ideas for the comprehensive management of patients with frailty.

Key words: Frailty, Trajectory of frailty, Longitudinal studies, Risk factors, Review

中图分类号:

R 364

贺洋,杨荣,沈灿,等. 衰弱轨迹及其影响因素研究进展[J]. 中国全科医学, 2026, 29(30): 4372-4378. DOI: 10.12114/j.issn.1007-9572.2024.0586.
HE Yang,YANG Rong,SHEN Can, et al. Progress in Research on the Trajectory of Frailty and Its Influencing Factors[J]. Chinese General Practice, 2026, 29(30): 4372-4378. DOI: 10.12114/j.issn.1007-9572.2024.0586.

图/表 1

参考文献 42

[1]	国际行动·第二次老龄问题世界大会[EB/OL].[2024-02-12].
[2]	联合国.第二次老龄问题世界大会的报告·政治宣言(附件一)[EB/OL].[2024-02-12].
[3]	郭楠, 解志山, 杨毅. 应对人口老龄化问题的养老产业投融资对策研究[J]. 华北理工大学学报(社会科学版), 2023, 23(5): 43-50, 55.
[4]	国家发展改革委规划司. "十四五"国家老龄事业发展和养老服务体系规划[EB/OL].[2024-02-12].
[5]	Hoogendijk E O, Afilalo J, Ensrud K E, et al. Frailty: implications for clinical practice and public health[J]. Lancet, 2019, 394(10206): 1365-1375. DOI: 10.1016/S0140-6736(19)31786-6.
[6]	Ma L N, Tang Z, Zhang L, et al. Prevalence of frailty and associated factors in the community-dwelling population of China[J]. J Am Geriatr Soc, 2018, 66(3): 559-564. DOI: 10.1111/jgs.15214.
[7]	Soysal P, Veronese N, Thompson T, et al. Relationship between depression and frailty in older adults: a systematic review and meta-analysis[J]. Ageing Res Rev, 2017, 36: 78-87. DOI: 10.1016/j.arr.2017.03.005.
[8]	Stenholm S, Ferrucci L, Vahtera J, et al. Natural course of frailty components in people who develop frailty syndrome: evidence from two cohort studies[J]. J Gerontol A Biol Sci Med Sci, 2019, 74(5): 667-674. DOI: 10.1093/gerona/gly132.
[9]	Li L, Wang Y G, Yang C L, et al. Frailty in hypertensive population and its association with all-cause mortality: data from the National Health and Nutrition Examination Survey[J]. Front Cardiovasc Med, 2023, 10: 945468. DOI: 10.3389/fcvm.2023.945468.
[10]	Chamberlain A M, St Sauver J L, Jacobson D J, et al. Social and behavioural factors associated with frailty trajectories in a population-based cohort of older adults[J]. BMJ Open, 2016, 6(5): e011410. DOI: 10.1136/bmjopen-2016-011410.
[11]	Jenkins N D, Hoogendijk E O, Armstrong J J, et al. Trajectories of frailty with aging: coordinated analysis of five longitudinal studies[J]. Innov Aging, 2022, 6(2): igab059. DOI: 10.1093/geroni/igab059.
[12]	Rogers N T, Fancourt D. Cultural engagement is a risk-reducing factor for frailty incidence and progression[J]. J Gerontol B Psychol Sci Soc Sci, 2020, 75(3): 571-576. DOI: 10.1093/geronb/gbz004.
[13]	Buchman A S, Yu L, Wilson R S, et al. Brain pathology contributes to simultaneous change in physical frailty and cognition in old age[J]. J Gerontol A Biol Sci Med Sci, 2014, 69(12): 1536-1544. DOI: 10.1093/gerona/glu117.
[14]	Stolz E, Mayerl H, Waxenegger A, et al. Impact of socioeconomic position on frailty trajectories in 10 European countries: evidence from the Survey of Health, Ageing and Retirement in Europe (2004-2013)[J]. J Epidemiol Community Health, 2017, 71(1): 73-80. DOI: 10.1136/jech-2016-207712.
[15]	Kim D H, Schneeweiss S, Glynn R J, et al. Measuring frailty in medicare data: development and validation of a claims-based frailty index[J]. J Gerontol A Biol Sci Med Sci, 2018, 73(7): 980-987. DOI: 10.1093/gerona/glx229.
[16]	Fried L P, Tangen C M, Walston J, et al. Frailty in older adults: evidence for a phenotype[J]. J Gerontol A Biol Sci Med Sci, 2001, 56(3): M146-M156. DOI: 10.1093/gerona/56.3.m146.
[17]	Quach J, Theou O, Pérez-Zepeda M U, et al. Effect of a physical activity intervention and frailty on frailty trajectory and major mobility disability[J]. J Am Geriatr Soc, 2022, 70(10): 2915-2924. DOI: 10.1111/jgs.17941.
[18]	Clegg A, Bates C, Young J, et al. Development and validation of an electronic frailty index using routine primary care electronic health record data[J]. Age Ageing, 2016, 45(3): 353-360. DOI: 10.1093/ageing/afw039.
[19]	Aguayo G A, Hulman A, Vaillant M T, et al. Prospective association among diabetes diagnosis, HbA_1c, glycemia, and frailty trajectories in an elderly population[J]. Diabetes Care, 2019, 42(10): 1903-1911. DOI: 10.2337/dc19-0497.
[20]	Rolfson D B, Majumdar S R, Tsuyuki R T, et al. Validity and reliability of the Edmonton frail scale[J]. Age Ageing, 2006, 35(5): 526-529. DOI: 10.1093/ageing/afl041.
[21]	Rogers N T, Marshall A, Roberts C H, et al. Physical activity and trajectories of frailty among older adults: Evidence from the English Longitudinal Study of Ageing[J]. PLoS One, 2017, 12(2): e0170878. DOI: 10.1371/journal.pone.0170878.
[22]	Rojas Huerta A V. Trajectories of frailty and related factors of elderly people in Mexico[J]. Poblac Salud Mesoam, 2022, 19(2): 10.15517/psm.v19i2.46929. DOI: 10.15517/psm.v19i2.46929.
[23]	Oberndorfer M, Mogg C, Haider S, et al. Partner loss and its effect on frailty trajectories: results from the 13-year follow-up Survey of Health, Ageing and Retirement in Europe (SHARE)[J]. J Epidemiol Community Health, 2022, 76(3): 209-215. DOI: 10.1136/jech-2021-216637.
[24]	Chen F N, Mair C A, Bao L M, et al. Race/ethnic differentials in the health consequences of caring for grandchildren for grandparents[J]. J Gerontol B Psychol Sci Soc Sci, 2015, 70(5): 793-803. DOI：10.1093/geronb/gbu160.
[25]	Hsu H C, Chang W C. Trajectories of frailty and related factors of the older people in Taiwan[J]. Exp Aging Res, 2015, 41(1): 104-114. DOI: 10.1080/0361073X.2015.978219.
[26]	Hoogendijk E O, Van Hout H P J, Heymans M W, et al. Explaining the association between educational level and frailty in older adults: results from a 13-year longitudinal study in the Netherlands[J]. Ann Epidemiol, 2014, 24(7): 538-544.e2. DOI: 10.1016/j.annepidem.2014.05.002.
[27]	郭雁飞, 阮晔, 孙双圆, 等. 中国50岁及以上人群衰弱的研究[J].中华流行病学杂志, 2022, 43(11): 1711-1716. DOI: 10.3760/cma.j.cn112338-20220528-00477.
[28]	Peek M K, Howrey B T, Ternent R S, et al. Social support, stressors, and frailty among older Mexican American adults[J]. J Gerontol B Psychol Sci Soc Sci, 2012, 67(6): 755-764.
[29]	Du J L, Zhang M, Zeng J P, et al. Frailty trajectories and determinants in Chinese older adults: a longitudinal study[J]. Geriatr Nurs, 2024, 59: 131-138. DOI: 10.1016/j.gerinurse.2024.06.015.
[30]	Stephan A J, Strobl R, Schwettmann L, et al. The times we are born into and our lifestyle choices determine our health trajectories in older age-results from the KORA-Age study[J]. Prev Med, 2020, 133: 106025. DOI: 10.1016/j.ypmed.2020.106025.
[31]	Binder E F, Yarasheski K E, Steger-May K, et al. Effects of progressive resistance training on body composition in frail older adults: results of a randomized, controlled trial[J]. J Gerontol A Biol Sci Med Sci, 2005, 60(11): 1425-1431. DOI: 10.1093/gerona/60.11.1425.
[32]	Gill T M, Baker D I, Gottschalk M, et al. A program to prevent functional decline in physically frail, elderly persons who live at home[J]. N Engl J Med, 2002, 347(14): 1068-1074. DOI: 10.1056/NEJMoa020423.
[33]	Howrey B T, Al Snih S, Middleton J A, et al. Trajectories of frailty and cognitive decline among older Mexican Americans[J]. J Gerontol A Biol Sci Med Sci, 2020, 75(8): 1551-1557.
[34]	Yuan Y Y, Lapane K L, Tjia J, et al. Trajectories of physical frailty and cognitive impairment in older adults in United States nursing homes[J]. BMC Geriatr, 2022, 22(1): 339.
[35]	He D, Qiu Y W, Yan M S, et al. Associations of metabolic heterogeneity of obesity with frailty progression: results from two prospective cohorts[J]. J Cachexia Sarcopenia Muscle, 2023, 14(1): 632-641. DOI: 10.1002/jcsm.13169.
[36]	Shen F F, Chen J Y, Yang R J, et al. Association between control status of blood pressure and frailty among middle-aged and older adults with hypertension in China: a longitudinal study[J]. BMJ Open, 2022, 12(3): e056395. DOI: 10.1136/bmjopen-2021-056395.
[37]	Rockwood M R H, Howlett S E. Blood pressure in relation to age and frailty[J]. Can Geriatr J, 2011, 14(1): 2-7. DOI: 10.5770/cgj.v14i1.1.
[38]	Tanaka T, Talegawkar S A, Jin Y C, et al. Metabolomic profile of different dietary patterns and their association with frailty index in community-dwelling older men and women[J]. Nutrients, 2022, 14(11): 2237. DOI: 10.3390/nu14112237.
[39]	Machado-Fragua M D, Hoogendijk E O, Struijk E A, et al. High dephospho-uncarboxylated matrix Gla protein concentrations, a plasma biomarker of vitamin K, in relation to frailty: the Longitudinal Aging Study Amsterdam[J]. Eur J Nutr, 2020, 59(3): 1243-1251.
[40]	Bouillon K, Batty G D, Hamer M, et al. Cardiovascular disease risk scores in identifying future frailty: the WhitehallⅡ prospective cohort study[J]. Heart, 2013, 99(10): 737-742. DOI: 10.1136/heartjnl-2012-302922.
[41]	Dalrymple L S, Katz R, Rifkin D E, et al. Kidney function and prevalent and incident frailty[J]. Clin J Am Soc Nephrol, 2013, 8(12): 2091-2099. DOI: 10.2215/CJN.02870313.
[42]	Newman A B, Gottdiener J S, Mcburnie M A, et al. Associations of subclinical cardiovascular disease with frailty[J]. J Gerontol A Biol Sci Med Sci, 2001, 56(3): M158-M166. DOI: 10.1093/gerona/56.3.m158.

评估工具	衰弱指数	Fried衰弱表型	Edmonton衰弱量表
包含内容	自我报告的健康状况、老年综合评估、基本和日常生活活动受限、视力和听力评估、行走平衡功能、既往诊断的疾病和使用的药物、日常生活活动能力、认知和情绪、抑郁、身体测量指标等30~92个健康变量（每个变量赋值1分）	①体质量下降：近半年内意外出现体质量下降>5 kg或>5%的体质量。②步速减慢：测量步行6 m所需的时间，计算步速，步速≤0.8 m/s为行走速度减慢。③握力下降：使用电子握力器测量优势手的握力，根据不同年龄、不同性别的握力标准进行判断。④活动量减少：调查研究对象在过去1周内的活动量，男性<383 kcal/周，女性<270 kcal/周为躯体活动量下降。⑤疲乏：使用以下2个问题中的1个进行评估：a.我感觉我做每一件事情都需要经过努力；b.我不能向前行走	①画钟测试2分；②住院次数2分；③健康状况2分；④日常活动是否需要他人帮助2分；⑤当需要帮助时，是否能找到帮助你的人2分；⑥是否服用5种以上处方药1分；⑦经常忘记服用药物1分；⑧因体质量减轻而感到衣服宽松1分；⑨情绪是否低落1分；⑩是否能控制住大小便1分；⑪能够独自完成体力劳动1分，步行2层楼梯或步行1 000 m 1分
计算方法	个体的健康缺陷数目除以健康缺陷总数的数值	"是"计1分，"否"计0分；总分范围为0~5分	①~⑤每项"是"计2分，"否"计0分；⑥~⑪每项"是"计1分，"否"计0分；总分范围为0~17分
结果解读	健康期（衰弱指数≤0.10）、衰弱前期（0.10<衰弱指数<0.25）和衰弱期（衰弱指数≥0.25）	0分为无衰弱，1~2分为衰弱前期，≥3分为衰弱	0~4分表示无衰弱，5~6分表示易出现衰弱的敏感人群，7~8分表示轻度衰弱，9~10分表示中度衰弱，11分或以上表示严重衰弱
优缺点	应用范围与评估维度广泛，更符合现代生物-心理-社会医学模式，但由于其需要评估的内容过多且繁琐，调查所需要的时间较长，更容易产生混杂干扰	侧重于老年人的生物学表现，观测指标数量不多且能客观定量，操作性较强，适用于临床机构应用；但该模式存在不足之处在于以及认知障碍等其他构成衰弱的躯体外因素未纳入测量范围	评估一般在5 min之内便可完成，简单便捷；但该量表中"健康状况"过于主观且不稳定

评估工具	衰弱指数	Fried衰弱表型	Edmonton衰弱量表
包含内容	自我报告的健康状况、老年综合评估、基本和日常生活活动受限、视力和听力评估、行走平衡功能、既往诊断的疾病和使用的药物、日常生活活动能力、认知和情绪、抑郁、身体测量指标等30~92个健康变量（每个变量赋值1分）	①体质量下降：近半年内意外出现体质量下降>5 kg或>5%的体质量。②步速减慢：测量步行6 m所需的时间，计算步速，步速≤0.8 m/s为行走速度减慢。③握力下降：使用电子握力器测量优势手的握力，根据不同年龄、不同性别的握力标准进行判断。④活动量减少：调查研究对象在过去1周内的活动量，男性<383 kcal/周，女性<270 kcal/周为躯体活动量下降。⑤疲乏：使用以下2个问题中的1个进行评估：a.我感觉我做每一件事情都需要经过努力；b.我不能向前行走	①画钟测试2分；②住院次数2分；③健康状况2分；④日常活动是否需要他人帮助2分；⑤当需要帮助时，是否能找到帮助你的人2分；⑥是否服用5种以上处方药1分；⑦经常忘记服用药物1分；⑧因体质量减轻而感到衣服宽松1分；⑨情绪是否低落1分；⑩是否能控制住大小便1分；⑪能够独自完成体力劳动1分，步行2层楼梯或步行1 000 m 1分
计算方法	个体的健康缺陷数目除以健康缺陷总数的数值	"是"计1分，"否"计0分；总分范围为0~5分	①~⑤每项"是"计2分，"否"计0分；⑥~⑪每项"是"计1分，"否"计0分；总分范围为0~17分
结果解读	健康期（衰弱指数≤0.10）、衰弱前期（0.10<衰弱指数<0.25）和衰弱期（衰弱指数≥0.25）	0分为无衰弱，1~2分为衰弱前期，≥3分为衰弱	0~4分表示无衰弱，5~6分表示易出现衰弱的敏感人群，7~8分表示轻度衰弱，9~10分表示中度衰弱，11分或以上表示严重衰弱
优缺点	应用范围与评估维度广泛，更符合现代生物-心理-社会医学模式，但由于其需要评估的内容过多且繁琐，调查所需要的时间较长，更容易产生混杂干扰	侧重于老年人的生物学表现，观测指标数量不多且能客观定量，操作性较强，适用于临床机构应用；但该模式存在不足之处在于以及认知障碍等其他构成衰弱的躯体外因素未纳入测量范围	评估一般在5 min之内便可完成，简单便捷；但该量表中"健康状况"过于主观且不稳定

衰弱轨迹及其影响因素研究进展

Progress in Research on the Trajectory of Frailty and Its Influencing Factors

RichHTML

PDF

可视化

摘要/Abstract

引用本文

使用本文

图/表 1

参考文献 42

相关文章 15

编辑推荐

Metrics

留言

[1]	赵家义, 樊剑, 于德华. 1秒率正常的肺功能受损人群现状、挑战及应对策略[J]. 中国全科医学, 2026, 29(30): 4366-4371.
[2]	李喜玲, 张帆, 杨欣月, 杨姮. "零食式锻炼"在慢性病管理中应用的范围综述[J]. 中国全科医学, 2026, 29(30): 4472-4479.
[3]	陈毓婧, 王岩, 李光, 董本超, 杨培川, 马剑雄. 数字技术在亚洲地区老年人肌少症干预中应用的范围综述[J]. 中国全科医学, 2026, 29(29): 4200-4210.
[4]	解霄芸, 刘晨曦, 柳羽姝, 周艺涵. 中国基层医疗卫生机构人工智能研究实践及潜在数据贫困问题：一项范围综述[J]. 中国全科医学, 2026, 29(28): 4067-4077.
[5]	冯雅晨, 刘乐伟, 薛金月, 孙先林, 刘寰忠. 可穿戴技术在精神障碍诊疗中的研究进展[J]. 中国全科医学, 2026, 29(27): 4016-4025.
[6]	刘振宇, 王文东, 姚清, 王江敏, 曹文栋. 北京市海淀区成人心血管-肾脏-代谢综合征的患病情况及影响因素研究[J]. 中国全科医学, 2026, 29(27): 3969-3975.
[7]	刘雅慧, 徐雅楠, 袁玲, 武丽桂, 周玉洁, 康玉彪. 基于优先级决策的安宁疗护患者分诊研究范围综述[J]. 中国全科医学, 2026, 29(24): 3538-3544.
[8]	张雪朝, 齐祺, 吴欣雨, 韩全乐, 李雷, 邓洁, 李藏妥, 岳博成, 吴寿岭, 李康博. 血浆致动脉粥样硬化指数与新发慢性肾病的关联研究[J]. 中国全科医学, 2026, 29(24): 3440-3446.
[9]	王睿, 罗说明, 杨靓, 王鹏, 赵洋, 王淇, 周智广. 中国老年人糖尿病患病率：一项系统综述和Meta分析[J]. 中国全科医学, 2026, 29(24): 3500-3508.
[10]	吴礼云, 孙华婧, 顾艺卿, 梅紫琦, 金胜姬, 张素菊, 诸赟, 张瑶, 李琴, 刘小苗, 王庆, 柏亚妹, 徐桂华. 数智化技术用于急性心肌梗死心电监测的范围综述[J]. 中国全科医学, 2026, 29(24): 3545-3552.
[11]	吴尔媚, 孙大娟, 邓华亮. 微小RNA在溃疡性结肠炎中的作用及中药干预研究进展[J]. 中国全科医学, 2026, 29(23): 3371-3378.
[12]	王龙雨, 李亚, 马倩, 贾沛霖, 张海龙. 肺一氧化碳弥散量在慢性阻塞性肺疾病中的临床应用研究进展[J]. 中国全科医学, 2026, 29(23): 3379-3384.
[13]	阮何静, 赵文, 李龙灿, 赵久法, 李冬冬. 帕金蛋白在代谢相关脂肪性肝病中的潜在非经典功能及治疗展望[J]. 中国全科医学, 2026, 29(23): 3268-3274.
[14]	王欣亮, 邹楠楠, 陈娜娜, 王欣. 肺毛霉病合并糖尿病的临床特征及预后危险因素研究[J]. 中国全科医学, 2026, 29(22): 3154-3161.
[15]	冯宇茜, 王津津, 蔡一, 朱润芝, 朱勤. 乳酸化修饰在肾脏疾病中的研究进展[J]. 中国全科医学, 2026, 29(21): 3056-3063.